Sagar Lonial, MD on The Applicability of Phase III TOURMALINE-MM4 Trial @SagarLonialMD @WinshipAtEmory

Sagar Lonial, MD @SagarLonialMD of Winship Cancer Institute @WinshipAtEmory discusses ixazomib vs placebo maintenance for NDMM patients not undergoing autologous stem cell transplant.

Read here: https://meetinglibrary.asco.org/record/186184/abstract